Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Homocysteine elevation with fibrates: is it a class effect?

D Harats1, O Yodfat, R Doolman

  • 1Institute of Lipid and Atherosclerosis Research, Sheba Medical Center, Tel-Hashomer, Israel. dharats@post.tau.ac.il

The Israel Medical Association Journal : IMAJ
|May 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Features of the metabolic syndrome and subclinical atherosclerosis in patients with cerebrotendinous xanthomatosis: An augmented risk for premature cardiovascular disease.

Frontiers in genetics·2022
Same author

The effect of α-linolenic acid enrichment in perinatal diets in preventing high fat diet-induced SCD1 increased activity and lipid disarray in adult offspring of low density lipoprotein receptor knockout (LDLRKO) mice.

Prostaglandins, leukotrienes, and essential fatty acids·2022
Same author

Early adverse events and immune response following COVID-19 booster vaccination in pregnancy.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
Same author

Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation.

Archives of toxicology·2018
Same author

High-Throughput Phenotyping in Plant Stress Response: Methods and Potential Applications to Polyamine Field.

Methods in molecular biology (Clifton, N.J.)·2017

Ciprofibrate significantly increases plasma homocysteine levels, while bezafibrate reduces them. This homocysteine elevation is reversible after stopping ciprofibrate treatment, indicating it

Area of Science:

  • Pharmacology and Cardiovascular Medicine
  • Lipid Metabolism and Atherosclerosis Research

Background:

  • Elevated plasma homocysteine is a significant risk factor for atherosclerotic vascular diseases.
  • Certain medications, including some lipid-lowering drugs, can influence homocysteine levels.
  • Previous studies suggest interactions between fibrates and homocysteine plasma levels.

Purpose of the Study:

  • To investigate the impact of different fibrate medications on plasma homocysteine levels.
  • To assess the reversibility of observed changes in homocysteine following fibrate treatment cessation.

Main Methods:

  • Evaluated ciprofibrate and bezafibrate effects on homocysteine in hyperlipidemia patients.
  • Measured homocysteine levels during 12 weeks of treatment and after a 6-week cessation period.

Related Experiment Videos

Main Results:

  • Ciprofibrate treatment led to a 57% increase in plasma homocysteine levels.
  • Bezafibrate treatment resulted in a 17% reduction in plasma homocysteine levels.
  • The homocysteine increase with ciprofibrate was sustained and partially reversible post-treatment.

Conclusions:

  • Fibrates do not uniformly affect homocysteine levels; the magnitude of change varies by drug.
  • The observed increase in plasma homocysteine with ciprofibrate is reversible upon drug discontinuation.